Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life ...

Colossal Biosciences aims to rewrite history as they work to resurrect extinct species – and their sights are set on the ...

Skye Bioscience reported favorable Phase 1b nimacimab results, with analysts citing strong potential in obesity alongside GLP-1 therapies.

It doesn’t feel like much of a ballroom. There’s no marble floor or orchestra, no opulent drapery or free-flowing champagne.

Get the latest analysis on Niagen Bioscience, including stock valuation, earnings update, and dilution risks. Learn if now is ...

A poster-size version of the front page of the very first issue of this magazine hangs in the lobby of Springer Nature’s New ...

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, announced last week the opening of a ...

Medicines Discovery Catapult (MDC) and Crown Bioscience have formed a strategic global collaboration to deliver an integrated translational biology platform for innovators developing ...

Construction is starting on The Hartford along Poyntz Avenue in downtown Manhattan. It is expected to be finished by the ...

If lawmakers fail to act, it'll derail the development of promising medical treatments and other cutting-edge technologies ...

Les Laboratoires Servier said that it agreed to acquire a potential treatment for Fragile X syndrome (FXS), the most common genetic cause of autism spectrum disorder (ASD), from its original developer ...

Plastic products frequently pile up in landfills or spill into natural habitats where they occupy space and endanger wildlife ...